Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Diagnostic and Interventional Imaging
|
April 8, 2015
Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features
A Dohan, S A Faraoun, M Barral, et al.
Gut
|
February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: current management
S P L Travis, E F Stange, M Lémann, et al.
Alimentary Pharmacology & Therapeutics
|
July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease
M Seirafi, B de Vroey, A Amiot, et al.
Gut
|
December 27, 2005
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial
P Marteau, M Lémann, P Seksik, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 4, 2021
A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire
R Leenhardt, A Koulaouzidis, D McNamara, et al.
Clinics and Research in Hepatology and Gastroenterology
|
April 3, 2019
Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized study
C Geffrier, V de Parades, L Abramowitz, et al.
Journal of Crohn'S & Colitis
|
December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID
A Buisson, J Filippi, A Amiot, et al.
Alimentary Pharmacology & Therapeutics
|
June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
A Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics
|
December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort
S Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Gut
|
January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
D Laharie, A Bourreille, J Branche, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Diagnostic and Interventional Imaging
|
April 8, 2015
Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features
A Dohan, S A Faraoun, M Barral, et al.
Gut
|
February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: current management
S P L Travis, E F Stange, M Lémann, et al.
Alimentary Pharmacology & Therapeutics
|
July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease
M Seirafi, B de Vroey, A Amiot, et al.
Gut
|
December 27, 2005
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial
P Marteau, M Lémann, P Seksik, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 4, 2021
A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire
R Leenhardt, A Koulaouzidis, D McNamara, et al.
Clinics and Research in Hepatology and Gastroenterology
|
April 3, 2019
Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized study
C Geffrier, V de Parades, L Abramowitz, et al.
Journal of Crohn'S & Colitis
|
December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID
A Buisson, J Filippi, A Amiot, et al.
Alimentary Pharmacology & Therapeutics
|
June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
A Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics
|
December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort
S Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Gut
|
January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
D Laharie, A Bourreille, J Branche, et al.
Page
of 18